ATE513929T1 - Gene mit einfluss auf die menschliche gedächtnisleistung - Google Patents
Gene mit einfluss auf die menschliche gedächtnisleistungInfo
- Publication number
- ATE513929T1 ATE513929T1 AT07777651T AT07777651T ATE513929T1 AT E513929 T1 ATE513929 T1 AT E513929T1 AT 07777651 T AT07777651 T AT 07777651T AT 07777651 T AT07777651 T AT 07777651T AT E513929 T1 ATE513929 T1 AT E513929T1
- Authority
- AT
- Austria
- Prior art keywords
- human memory
- affecting human
- memory performance
- genes affecting
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76271306P | 2006-01-27 | 2006-01-27 | |
US86219406P | 2006-10-19 | 2006-10-19 | |
PCT/US2007/061112 WO2007120955A2 (en) | 2006-01-27 | 2007-01-26 | Genes affecting human memory performance |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE513929T1 true ATE513929T1 (de) | 2011-07-15 |
Family
ID=38610268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07777651T ATE513929T1 (de) | 2006-01-27 | 2007-01-26 | Gene mit einfluss auf die menschliche gedächtnisleistung |
Country Status (7)
Country | Link |
---|---|
US (1) | US7993836B2 (de) |
EP (1) | EP1987165B1 (de) |
JP (1) | JP5191906B2 (de) |
AT (1) | ATE513929T1 (de) |
AU (1) | AU2007238541A1 (de) |
CA (1) | CA2638802A1 (de) |
WO (1) | WO2007120955A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008019395A2 (en) * | 2006-08-10 | 2008-02-14 | Translational Genomics Research Institute | Compounds for improving learning and memory |
TW201030337A (en) * | 2009-02-04 | 2010-08-16 | Tzu Chi Buddhist General Hospital | Method and kit for detecting cancers |
EP2354789A1 (de) | 2010-02-08 | 2011-08-10 | Sygnis Bioscience GmbH & Co. KG | Verfahren zur Identifizierung von gedächtnismodulierenden Verbindungen durch Auswertung der KIBRA-Expression |
WO2013041239A1 (en) * | 2011-09-21 | 2013-03-28 | Sygnis Bioscience Gmbh & Co. Kg | Pkm zeta bindin peptides, peptide derivatives and conjugates, and uses thereof |
WO2013041238A1 (en) * | 2011-09-21 | 2013-03-28 | Sygnis Bioscience Gmbh & Co. Kg | Use of kibra peptides, hdac inhibitor or proteasome inhibitor for improving anxiety disorders |
CN116925205A (zh) * | 2022-04-07 | 2023-10-24 | 复旦大学 | 激活Hippo信号通路的多肽及其用途 |
CN114457154B (zh) * | 2022-04-13 | 2022-06-28 | 山东第一医科大学附属省立医院(山东省立医院) | KIBRA rs17070145检测试剂在制备嗅觉功能评价试剂盒中的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5993054A (ja) * | 1982-11-18 | 1984-05-29 | Asahi Chem Ind Co Ltd | イソキノリンスルホン酸アミド誘導体 |
US4678783B1 (en) * | 1983-11-04 | 1995-04-04 | Asahi Chemical Ind | Substituted isoquinolinesulfonyl compounds |
DE3583287D1 (de) | 1984-12-27 | 1991-07-25 | Asahi Chemical Ind | Substituierte isochinolinsulfonyl-verbindungen. |
JPH0667926B2 (ja) * | 1985-11-12 | 1994-08-31 | 旭化成工業株式会社 | 環状のイソキノリンスルホンアミド誘導体 |
JP3464012B2 (ja) | 1993-04-05 | 2003-11-05 | 旭化成株式会社 | 精神症候治療剤 |
KR100236853B1 (ko) * | 1995-07-03 | 2000-02-01 | 야마모토 카즈모토 | 1-(5-이소퀴놀린술포닐)호모피페라진 염산염 수화물 |
EP1110553B1 (de) * | 1998-08-10 | 2013-03-27 | Asahi Kasei Pharma Corporation | Orale zusammensetzungen zur kontrollierten freisetzung von fasudil hydrochlorid |
ZA200302044B (en) | 2000-09-14 | 2004-03-15 | Univ Zuerich | Calcium binding proteins. |
CA2533803A1 (en) * | 2003-07-29 | 2005-02-10 | Bristol-Myers Squibb Company | Biomarkers of cyclin-dependent kinase modulation |
KR100565056B1 (ko) | 2003-08-14 | 2006-03-30 | 삼성전자주식회사 | Av 데이터를 enav 모드로 재생하는 방법, 그 장치및 그 정보저장매체 |
WO2008019395A2 (en) * | 2006-08-10 | 2008-02-14 | Translational Genomics Research Institute | Compounds for improving learning and memory |
-
2007
- 2007-01-26 WO PCT/US2007/061112 patent/WO2007120955A2/en active Application Filing
- 2007-01-26 EP EP07777651A patent/EP1987165B1/de not_active Not-in-force
- 2007-01-26 JP JP2008552587A patent/JP5191906B2/ja not_active Expired - Fee Related
- 2007-01-26 AT AT07777651T patent/ATE513929T1/de active
- 2007-01-26 AU AU2007238541A patent/AU2007238541A1/en not_active Abandoned
- 2007-01-26 US US12/162,262 patent/US7993836B2/en not_active Expired - Fee Related
- 2007-01-26 CA CA002638802A patent/CA2638802A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2007238541A1 (en) | 2007-10-25 |
EP1987165A4 (de) | 2010-01-27 |
JP5191906B2 (ja) | 2013-05-08 |
US20090227500A1 (en) | 2009-09-10 |
WO2007120955A3 (en) | 2008-02-14 |
WO2007120955A2 (en) | 2007-10-25 |
US7993836B2 (en) | 2011-08-09 |
EP1987165B1 (de) | 2011-06-22 |
JP2009524437A (ja) | 2009-07-02 |
EP1987165A2 (de) | 2008-11-05 |
CA2638802A1 (en) | 2007-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012722A (es) | Variantes geneticas sobre chr 5p12 y 10q26 como marcadores para el uso en la evaluacion del riesgo, diagnostico, pronostico y tratamiento del cancer de mama. | |
EA200800087A1 (ru) | Генетические варианты гена tcf7l2 как диагностические маркеры риска возникновения сахарного диабета ii типа | |
ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
WO2004066941A3 (en) | Expression profiles for colon cancer and methods of use | |
ATE513929T1 (de) | Gene mit einfluss auf die menschliche gedächtnisleistung | |
EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
CR9315A (es) | Metodos y sistemas para el diagnostico, pronostico y seleccion del tratamiento de la leucemia | |
EA200970891A1 (ru) | Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы | |
HN2008000346A (es) | Secuencias de nucleotidos que codifican proteinas insecticidas | |
NO20092023L (no) | Oligoribonuleotider og anvendelser derav | |
WO2010062960A3 (en) | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE | |
WO2010004591A3 (en) | Genetic variants for breast cancer risk assessment | |
WO2005059108A3 (en) | Gene expression profiles and methods of use | |
WO2007058968A3 (en) | Gene expression profiles and methods of use | |
MX2010001993A (es) | Metodos y composiciones para diagnosticar una enfermedad. | |
ATE534738T1 (de) | Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen | |
WO2004078035A3 (en) | Expression profiles for breast cancer and methods of use | |
EP2423684A3 (de) | Profilbestimmungsanalyse der differentiellen Expression von Zellkulturph. und Verwendung damit | |
TW200716132A (en) | Novel chemical compounds | |
DE60302350D1 (de) | Verwendung von adenoviren mit mutationen in den va-genen für die krebstherapie | |
ATE446385T1 (de) | Polymorphismen im nod2/card15 gen | |
NO20021147D0 (no) | Polymorfismer i det humane hPXR-genet og deres anvendelse i diagnostiske og terapeutiske applikasjoner | |
NO20052956D0 (no) | Defensinprotiner | |
TW200716579A (en) | Novel chemical compounds | |
ATE533861T1 (de) | Mipol1-etv1-gen-neuanordnungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1987165 Country of ref document: EP |